scispace - formally typeset
Open AccessJournal Article

Macrophages ingest and are activated by bacterial DNA.

TLDR
Results suggest that DNA is taken up by macrophages and characteristic bacterial DNA sequences, which include an unmethylated CpG sequence, activate a signaling cascade leading to activation of NF-kappa B and inflammatory gene induction.
Abstract
Recent evidence suggests that bacterial DNA activates immune responses Here we showed that TNF-alpha mRNA was induced in bone marrow-derived macrophages and the macrophage cell line RAW 264 by plasmid DNA, but not by DNaseI-digested plasmid, plasmid methylated on CpG dinucleotides, or by vertebrate genomic DNA, which is naturally largely methylated on these sequences Synthetic polynucleotides poly d(I-C) and poly I x poly C also induced TNF-alpha IL-1 beta and plasminogen activator inhibitor-2 mRNAs were induced by plasmid DNA, and IFN-gamma-pretreated macrophages responded to DNA with induction of inducible nitric oxide synthase The HIV-1 long terminal repeat was activated by exogenous DNA in a manner similar to TNF-alpha, and was also activated by a CpG-containing oligonucleotide Transcription factor nuclear factor-kappa B (NF-kappa B) is involved in regulation of the HIV-1 long terminal repeat and many inflammatory response genes NF-kappa B binding activity was increased by plasmid DNA An important question is whether these effects involve DNA binding to a cell surface receptor that signals to the interior, or whether internalization is necessary Here we found that plasmid was taken up by RAW 264 cells and remained sufficiently intact to code for luciferase protein Results suggest that DNA is taken up by macrophages and characteristic bacterial DNA sequences, which include an unmethylated CpG sequence, activate a signaling cascade leading to activation of NF-kappa B and inflammatory gene induction Relevance to DNA vaccination, gene therapy, antisense, and transfection studies is discussed

read more

Citations
More filters
Journal ArticleDOI

CpG Motifs in Bacterial DNA and Their Immune Effects

TL;DR: Oligodeoxynucleotides containing CpG ODN enhance the development of acquired immune responses for prophylactic and therapeutic vaccination and protect against lethal challenge with a wide variety of pathogens.
Journal ArticleDOI

DNA vaccines: immunology, application, and optimization*.

TL;DR: This review focuses on the mechanisms by which DNA vaccines elicit immune responses, and a list of potential applications in a variety of preclinical models is provided.
Journal ArticleDOI

Toll-like receptors and innate immunity

TL;DR: The recent advances in pathogen recognition by TLRs and TLR signaling are described and their roles in shaping pathogen-specific humoral and cellular adaptive immune responses are described.
Journal ArticleDOI

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity.

TL;DR: CpG ODN provide a signal to switch on Th1-dominated responses to coadministered antigen and are potential adjuvants for human vaccines to elicit protective Th1 immunity.
Journal ArticleDOI

Immunotherapeutic uses of CpG oligodeoxynucleotides

TL;DR: Ongoing clinical studies indicate that CpG ODN use is safe in humans, and that they modulate the immune response to co-administered allergens and vaccines.
Related Papers (5)